About Alephoson Biopharmaceuticals Limited
Alephoson Biopharmaceuticals LimitedAlephoson Biopharmaceuticals Limited (AB) is a private, technology-based company focusing on research and development of innovative drug delivery technologies to fulfil unmet medical needs. By utilizing the destructive, and proprietary next generation Cell Penetration Protein Alternation Technology (CePPA), we are working to overcome the limitations of current treatments for serious ophthalmic diseases by developing a topical eye drop alternative to intravitreal (back-of-the eye) injection therapies.
